CERO THERAPEUTICS HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cero Therapeutics Holdings, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q3 2024.
  • Cero Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $400K.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $400K Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-20
Q2 2024 $30K -$1.37M -97.9% Apr 14, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $90K +$61.9K +220% Feb 14, 2024 Mar 31, 2024 10-Q 2024-05-17
Q2 2023 $1.4M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $28.1K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.